Compliance Team
Angels Den

Dear User,

You may have heard about the new General Data Protection Regulation (“GDPR”), that comes into effect May 25, 2018.

We would like to ensure you that your personal data is safe with us. Please read the details regarding the processing of your personal data and if you agree with the processing as described below, please click the ‘I agree’ button.

Please be informed that you can withdraw this consent at any time.

1) What data are we talking about?

We are disclosing details regarding the processing of personal data that is collected within our calls and in connection with your use of Angels Den’s platform, Websites and other functionalities of Angels Den, including those saved in cookies files.

2) Who will be the controller of your data?

Angels Den Funding Limited (hereinafter referred to as AD) will be the controller of your data (Angels Den means all entities from the Angels Den capital group, which includes Angels Den Funding Limited with its registered office in London and all entities related to it and dependent on it) and only our Trusted Partners.

3) Why do we want to process your data?

We process this data for the purposes described in our Privacy Policy, including:
- compliance with any legal requirements and obligations,
- ensuring that content from our Website is presented in the most effective manner for you,
- marketing purposes,
- providing you with our services (including the completion and support of immediate activity required to provide you with information and deliver products and/or services that you request and to deliver any contracts entered into with you), or
- as otherwise explained in this privacy policy or by any communication by us.
Where you have explicitly consented to be contacted for such purposes, we use your personal data to provide information on our new and existing products and services.

4) To whom can we transfer data?

In accordance with applicable law, we may transfer your data to entities processing it at our request, e.g. marketing agencies, subcontractors of our services and entities authorized to obtain data under applicable law, e.g. courts or law enforcement agencies - of course only if they submit a request based on an applicable legal basis. Furthermore, we will transfer your data to Trusted Partners outside the European Union – to the USA – under the EU-U.S. Privacy Shield Framework.

5) What are your rights to your data?

You have the right to request access to, correct, delete your personal data. You can also withdraw consent to processing of personal data, raise objections and use other rights granted under GDPR (i.e. right to data portability).

6) Use of cookies

We use cookies to give you the best experience on our Website. This means that we have placed cookies on your device. If you continue without changing your cookie settings, we assume that you consent to our use of cookies on this device. You can change your cookie settings at any time but if you do, you may lose some functionality on our Website. More information can be found in our Privacy Policy.

In connection with the above, I agree to the processing of my personal data by Angels Den and its Trusted Partners. I confirm that I understand that my personal data is being collected as part of my phone calls, use of AD’s online platform, Websites, and other functionalities of AD, including the data saved in cookie files. I also consent to profiling in order to allow Angels Den and its Trusted Partners the provision of better services (including for analytical purposes). Your data will only be processed on a valid lawful basis in accordance with applicable data protection laws. The processing of your personal data for marketing purposes (including statistical analysis) by AD is based on the firm's legitimate interest. The processing for marketing purposes by our Trusted Partners is only possible if we receive your freely given consent. We will also process your personal data to fulfil our contractual obligations to you as contained in AD’s Terms and Conditions of the use of our Website and services. Therefore, this data will be processed on another lawful basis – ‘contract’. We will also process your data to comply with our legal obligations for our Service (such as anti money laundering and know your customer requirements), which is also a valid lawful basis in accordance with applicable data protection laws.

Expressing this consent is voluntary and you can withdraw at any time.

If you have any doubts or questions about the use of your personal data, please do not hesitate to contact me via email. I’m happy to assist.

Compliance Team
Angels Den
cl@angelsden.com

  • £ 413,000 FUNDED SO FAR (118 %)
  • £ 500,000 MAXIMUM TARGET
  • 14.29% EQUITY
  • 0 DAYS
  • SIGN IN TO SEE MORE
118%

STROLLL - Investment Opportunity

Parkinson's Disease "Sucks" - Michael J. Fox It robs millions of people of their mobility and independence every year and we're not doing enough to provide effective treatment. Strolll exists to redefine the everyday 'reality' of neurological disorders through cue'd movement. We've taken the science and clinical knowledge of sensory cueing and combined this with immersive technology (MR/AR Glasses) to create Cue X, a medical device (MR glasses + cueing software) for assistance, treatment and diagnostics in neurological disorders, starting with Parkinson's Disease.

LIVE PITCHING

Strolll's co-founder and CEO Jorgen Ellis pitching at one of Angels Den's events.

You have to log in or register to see this information.
THE IDEA
Products & Services

Strolll is a software as a medical device (SaaMD) business. We've created software for both at home (d2c) and in the clinic, (b2b) and one that spans and connects the multidisciplinary care team involved in Parkinson's Disease, from the individual to the neurologist. The Cue X device is designed around three core elements, Enable, Engage, Measure.

1. To enable movement, by providing the widest range and types of cue's which can be personalised to the individual.(Assistance)
2. To engage users through digital physiotherapy delivered in mixed reality.(Treatment)
3. To measure user movement data, and provide visibility of treatment outcomes and disease progression over time.(Diagnostics)

Problem Solved

PD is a progressive movement disorder, often associated with a tremor, but it also has other motor symptoms namely an impaired walking ability or balance, and rigidity; which get worse over time and are detrimental to a person's quality of life. In a survey of more than 1000 people affected by PD, balance and falls were rated the number one priority area for research.

Strolll's Cue X device is an innovative medical device that specifically addresses balance and falls in PD and is designed to assist, treat and measure a person's gait using sensory cueing, further advanced by the capability for precision medicine & personalisation, supported by strolll's proprietary machine learning & AI

Revenue Model

Strolll is predominantly a SaaMD business. The Cue X device (Combined hardware rental (glasses) and Software) will be sold as a single monthly subscription, with additional add-on services for physiotherapy and clinical applications for treatment assessment and diagnostics. Strolll also has an ancillary one-off physical product, which will be sold via e-commerce as a strategic enabler for the cue X device.

Exit Strategy
You have to log in or register to see this information.
Minimum Target £ 350,000 Maximum Target £ 500,000 Minimum investment amount £ 10,000 Maximum investment amount £ 500,000
Share On Website Visit site Location LONDON
Gallery

The Idea

Products & Services

Strolll is a software as a medical device (SaaMD) business. We've created software for both at home (d2c) and in the clinic, (b2b) and one that spans and connects the multidisciplinary care team involved in Parkinson's Disease, from the individual to the neurologist. The Cue X device is designed around three core elements, Enable, Engage, Measure.

1. To enable movement, by providing the widest range and types of cue's which can be personalised to the individual.(Assistance)
2. To engage users through digital physiotherapy delivered in mixed reality.(Treatment)
3. To measure user movement data, and provide visibility of treatment outcomes and disease progression over time.(Diagnostics)

Problem Solved

PD is a progressive movement disorder, often associated with a tremor, but it also has other motor symptoms namely an impaired walking ability or balance, and rigidity; which get worse over time and are detrimental to a person's quality of life. In a survey of more than 1000 people affected by PD, balance and falls were rated the number one priority area for research.

Strolll's Cue X device is an innovative medical device that specifically addresses balance and falls in PD and is designed to assist, treat and measure a person's gait using sensory cueing, further advanced by the capability for precision medicine & personalisation, supported by strolll's proprietary machine learning & AI

Revenue Model

Strolll is predominantly a SaaMD business. The Cue X device (Combined hardware rental (glasses) and Software) will be sold as a single monthly subscription, with additional add-on services for physiotherapy and clinical applications for treatment assessment and diagnostics. Strolll also has an ancillary one-off physical product, which will be sold via e-commerce as a strategic enabler for the cue X device.

Exit Strategy
You have to log in or register to see this information.
You have to log in or register to see this information.
You have to log in or register to see this information.
You have to log in or register to see this information.
You have to log in or register to see this information.
You have to log in or register to see this information.
You have to log in or register to see this information.
  • £ 413,000 FUNDED SO FAR (118 %)
  • £ 500,000 MAXIMUM TARGET
  • 14.29% EQUITY
  • 0 DAYS
  • SIGN IN TO SEE MORE
118%